Tenaya Therapeutics, Inc. (TNYA)
0.8573
-0.08
(-8.31%)
USD |
NASDAQ |
May 15, 16:00
0.84
-0.02
(-2.02%)
After-Hours: 20:00
Tenaya Therapeutics Shareholders Equity (Quarterly) : 106.19M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 13.80M |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Krystal Biotech, Inc. | 1.277B |
| Vericel Corp. | 356.23M |
| Anavex Life Sciences Corp. | 126.62M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 135.07M |
| Total Liabilities (Quarterly) | 28.88M |
| Debt to Equity Ratio | 0.0953 |
| Current Ratio | 5.754 |
| Net Debt Paydown Yield | 0.46% |